alpha-2-delta LIGAND TO TREAT LOWER URINARY TRACT SYMPTOM

PROBLEM TO BE SOLVED: To provide a compound useful as a medicament for the treatment of LUTS, other than urinary incontinence, associated with OAB and/or BPH. SOLUTION: Use of an α-2-δ ligand, or a pharmaceutically acceptable derivative thereof, for the manufacture of the medicament for the treatmen...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	WESTBROOK SIMON LEMPRIER, TAYLOR CHARLES PRICE JR, THORPE ANDREW JOHN, WUSTROW DAVID JUERGEN
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PROBLEM TO BE SOLVED: To provide a compound useful as a medicament for the treatment of LUTS, other than urinary incontinence, associated with OAB and/or BPH. SOLUTION: Use of an α-2-δ ligand, or a pharmaceutically acceptable derivative thereof, for the manufacture of the medicament for the treatment of LUTS, other than urinary incontinence, associated with OAB and/or BPH is provided. Preferred α-2-δ ligands include gabapentin, pregabalin, (1α,3α,5α)(3-amino-methyl-bicyclo[3.2.0]hept-3-yl)-acetic acid, 4-(3-fluoro-benzyl)-pyrrolidine-2-carboxylic acid, etc. COPYRIGHT: (C)2011,JPO&INPIT